Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Respiratory Safety of Lemborexant in Adult and Elderly Healthy Subjects and Adult and Elderly Subjects With Mild Obstructive Sleep Apnea

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Respiratory Safety of Lemborexant in Adult and Elderly Healthy Subjects and Adult and Elderly Subjects With Mild Obstructive Sleep Apnea

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 11 Jun 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Lemborexant (Primary)
  • Indications Sleep apnoea syndrome
  • Focus Pharmacodynamics; Therapeutic Use
  • Sponsors Eisai Inc
  • Most Recent Events

    • 11 Jun 2019 According to an Eisai Inc media release, results from the study were presented at the 33rd annual meeting of the Associated Professional Sleep Societies (SLEEP 2019).
    • 11 Jun 2019 Results presented in an Eisai Inc media release.
    • 28 May 2019 According to an Eisai Co Ltd media release, the company today announced the results of this study will be presented at the 33rd annual meeting of the Associated Professional Sleep Societies (SLEEP 2019) June 10 in San Antonio.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top